ProShares Trust ProShares Bitcoin & Ether Market Cap Weight Strategy ETF BETH 深 沪
已收盘 11-07 16:00:00 美东时间
67.3168
+2.040
+3.12%
华盛通- 最 高67.3168
- 今 开64.42
- 成交量 5515股
- 最 低 64.42
- 昨 收 65.2769
- 总市值 1279.02万
- 52周最高 84.1683
- 市盈率 静 --
- 换手率 2.90%
- 52周最低 40.8851
- 委 比 0.00%
- 总股本 19.00万
- 历史最高 77.1162
- 量 比 1.00
- 振 幅 4.44%
- 历史最低 -2.5027
- 每 手 1
- 风险率 10.10%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Centrus Announces "At-the-Market" Equity Offering Program
BETHESDA, Md., Nov. 6, 2025 /PRNewswire/ -- Centrus Energy Corp. (NYSE American: LEU) ("Centrus") today announced that it has entered into an at-the-market ("ATM") equity offering sales agre...
11-06 21:14
Choice Privileges Announces an All-New Rewards Experience that Offers More Rewards, More Often
The award-winning program is raising the bar in loyalty by offering more to members: rewards every five nights, a new Titanium tier, and more ways to reach status—faster NORTH BETHESDA, Md....
11-05 00:06
特朗普出尔反尔，加密市场惨遭血洗：从312到1011，BTC要多久能再创新高？
加密市场迎来了史上最大规模清算行情，10月11日清晨，很多从梦中醒来的加密投资者都以为自己看错了行情。 特朗普出尔反尔引爆市场 10月10日晚间，特朗普在其社交...
10-11 15:13
Lockheed Martin Declares Fourth Quarter 2025 Dividend
BETHESDA, Md., Oct. 9, 2025 /PRNewswire/ -- The Lockheed Martin Corporation (NYSE: LMT) board of directors has authorized a fourth quarter 2025 dividend of $3.45 per share. This is an increa...
10-10 06:15
Gain Therapeutics Presents Phase 1b GT-02287 Data At International Congress Of Parkinson's Disease And Movement Disorders, Highlighting Safety, Tolerability, And Exploratory Findings In PD Patients With or Without GBA1 Mutation
Improvement observed in MDS-UPDRS scores in first 9 participants enrolled; 90-day follow-up continuing in remaining participantsPlasma exposures in patients within projected therapeutic range and comparable to exposures
10-06 20:20
Saul Centers Declares Quarterly Dividends
BETHESDA, Md., Sept. 23, 2025 /PRNewswire/ -- Saul Centers, Inc. (NYSE: BFS) has declared a quarterly dividend of $0.59 per share on its common stock, to be paid on October 31, 2025, to hold...
09-24 05:16
Gain Therapeutics Begins GT-02287 Phase 1b Extension Study Allowing Participants To Continue Treatment For Additional Nine Months
Extension of the Phase 1b study will allow participants to continue dosing with GT-02287 for an additional nine months after completing the first 90-day dosing scheduleThe Phase 1b study enrolled 21 subjects and the last
09-18 19:45
Choice Hotels International Announces Quarterly Cash Dividend
Board Approves Dividend of $0.2875 Per Share on the Company's Common Stock NORTH BETHESDA, Md., Sept. 10, 2025 /PRNewswire/ -- Choice Hotels International, Inc. (NYSE: CHH), one of the worl...
09-11 02:11
Everhome Suites Marks Major Milestone with Multi-Market Growth Surge
Everhome Brand Enters High-Barrier Markets with Speed and Scale, Signaling Strong Developer Confidence and Operational Momentum NORTH BETHESDA, Md., Sept. 3, 2025 /PRNewswire/ -- Everhome Su...
09-03 20:00
Centrus Energy to Participate in Upcoming Investor Events
BETHESDA, Md., Aug. 29, 2025 /PRNewswire/ -- Centrus Energy Corp. (NYSE American: LEU) today announced that management will participate in the following upcoming conferences. On Tuesday, Sep...
08-30 05:25
